focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Distribution Agreement

10 Apr 2013 07:00

RNS Number : 9680B
Omega Diagnostics Group PLC
09 April 2013
 



 

Omega Diagnostics Group PLC

("Omega" or the "Company")

 

Distributor Agreement

 

10 April 2013

 

 

Omega (AIM:ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, is pleased to announce it has agreed to amend the Terms of its existing licence agreement with Immunodiagnostic Systems Holdings plc (IDS) allowing the Company to appoint IDS as its exclusive distributor in certain territories for allergy tests to be run on the automated IDS-iSYS platform. The countries covered by the agreement are those countries where IDS already has a direct presence, namely, the USA, Germany, France, the Nordic regions and the UK.

 

It is envisaged that the Company and IDS will enter into a distribution agreement in due course which will provide IDS customers with an increased menu of tests on the IDS-iSYS platform and will allow Omega to reduce its time to market in the selected countries. The Company is still developing an initial launch panel of 40+ allergy tests with a planned launch date in the final quarter of the new financial year ending 31 March 2014.

 

 

 

 

Contacts:

 

Omega Diagnostics Group PLC Tel: 01259 763 030

Andrew Shepherd, Chief Executive www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director

Jag Grewal, Group Sales and Marketing Director

finnCap Ltd Tel: 020 7220 0500

Geoff Nash/Christopher Raggett (Corporate Finance)

Stephen Norcross/Mia Gardner (Corporate Broking)

Walbrook PR Limited Tel: 020 7933 8780

Paul McManus Mob: 07980 541 893; paul.mcmanus@wallbrookpr.com

Lianne Cawthorne Mob: 07584 391 303; lianne.cawthorne@walbrookpr.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRNKCDBBBKBCQK
Date   Source Headline
4th Jan 20224:36 pmRNSPrice Monitoring Extension
14th Dec 20217:00 amRNSConfirmation of detection of Omicron variant
10th Dec 20212:06 pmRNSSecond Price Monitoring Extn
10th Dec 20212:01 pmRNSPrice Monitoring Extension
10th Dec 20219:30 amRNSDHSC contract update
1st Dec 20214:40 pmRNSSecond Price Monitoring Extn
1st Dec 20214:35 pmRNSPrice Monitoring Extension
1st Dec 20212:05 pmRNSSecond Price Monitoring Extn
1st Dec 20212:00 pmRNSPrice Monitoring Extension
26th Nov 20212:06 pmRNSSecond Price Monitoring Extn
26th Nov 20212:00 pmRNSPrice Monitoring Extension
25th Nov 20219:06 amRNSSecond Price Monitoring Extn
25th Nov 20219:00 amRNSPrice Monitoring Extension
25th Nov 20217:00 amRNSHalf-year Report
5th Nov 20217:00 amRNSNotice of Results and Investor Presentation
3rd Nov 20217:00 amRNSUpdate on CTDA Regulations
1st Nov 20213:28 pmRNSExercise of Options and Total Voting Rights
1st Nov 20217:00 amRNSPartnership with DAM Health and initial LFT order
19th Oct 202112:00 pmRNSExercise of Options and Total Voting Rights
15th Sep 20213:26 pmRNSResult of AGM
15th Sep 20217:00 amRNSAGM Statement
30th Jul 202112:35 pmRNSPosting of Annual Report & Accounts &Notice of AGM
27th Jul 20217:00 amRNSAbC-19 monitors vaccine response to variants
13th Jul 20217:01 amRNSFinal Results
13th Jul 20217:00 amRNSDirectorate Change
9th Jul 20219:08 amRNSAbC-19 rapid antibody test performance evaluation
2nd Jul 20217:00 amRNSFDA submission for Emergency Use Authorization
16th Jun 20217:00 amRNSNotice of Results
15th Jun 202110:49 amRNSStatement re. Media Comment
10th Jun 20212:05 pmRNSSecond Price Monitoring Extn
10th Jun 20212:00 pmRNSPrice Monitoring Extension
8th Jun 20217:00 amRNSRegulatory progress for VISITECT® COVID-19 test
7th Jun 20217:00 amRNSProgress update
1st Jun 20217:00 amRNSPositive data for COVID-19 antigen test
6th May 20214:41 pmRNSSecond Price Monitoring Extn
6th May 20214:35 pmRNSPrice Monitoring Extension
5th May 20217:00 amRNSPositive data for Mologic COVID-19 antigen test
30th Apr 20211:30 pmRNSExercise of Options and Total Voting Rights
30th Apr 20217:00 amRNSLaunch of VISITECT® COVID-19 Antigen & Update
23rd Apr 202110:30 amRNSDirector/PDMR Shareholding and Total Voting Rights
19th Apr 20217:00 amRNSDirector/PDMR Shareholding
31st Mar 202112:31 pmRNSDirector/PDMR Shareholding and Total Voting Rights
26th Mar 20215:36 pmRNSExercise of Options and Total Voting Rights
26th Mar 20214:40 pmRNSSecond Price Monitoring Extn
26th Mar 20214:35 pmRNSPrice Monitoring Extension
22nd Mar 20217:00 amRNSCE-Mark: Mologic COVID19 lateral flow antigen test
19th Mar 20211:15 pmRNSExercise of Options and Total Voting Rights
15th Mar 20215:28 pmRNSStatement re. Government press release
15th Mar 20217:00 amRNSUK Public Sector Contract disclosure
8th Mar 20217:00 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.